Explore more publications!
The Boston Examiner
Got News to Share?

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 6, 2026

Explosive CAGR Trends Reshape Global Markets: Energy Transition and Next-Gen Medicine Accelerate
January 6, 2026

Explosive CAGR Trends Reshape Global Markets: Energy Transition and Next-Gen Medicine Accelerate

Indeterminate GlobeNewswire
Bullhorn Expands SIA | Bullhorn Staffing Indicator with New IT Staffing Indicator
January 6, 2026

Bullhorn Expands SIA | Bullhorn Staffing Indicator with New IT Staffing Indicator

Indeterminate GlobeNewswire
Semiconductor Silicon Wafer Market Set to Reach $20.2 Billion Globally by 2030
January 6, 2026

Semiconductor Silicon Wafer Market Set to Reach $20.2 Billion Globally by 2030

Indeterminate GlobeNewswire
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
January 6, 2026

Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV

Indeterminate GlobeNewswire
GasBuddy: Yearly Average Gas Prices to Fall Below $3 in 2026 — Lowest Since 2020
January 6, 2026

GasBuddy: Yearly Average Gas Prices to Fall Below $3 in 2026 — Lowest Since 2020

Indeterminate GlobeNewswire
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
January 6, 2026

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study

Indeterminate GlobeNewswire
LiquidStack Secures 300-Megawatt CDU Order from Major U.S. Data Center Operator
January 6, 2026

LiquidStack Secures 300-Megawatt CDU Order from Major U.S. Data Center Operator

Indeterminate GlobeNewswire
Paytronix Introduces SMS Enrollment Functionalities for Guests and Operators
January 6, 2026

Paytronix Introduces SMS Enrollment Functionalities for Guests and Operators

Indeterminate GlobeNewswire
Progress Software to Report Fourth Quarter 2025 and Full Year Financial Results on January 20, 2026
January 6, 2026

Progress Software to Report Fourth Quarter 2025 and Full Year Financial Results on January 20, 2026

Indeterminate GlobeNewswire
Payscale Customer Cheyenne Regional Medical Center Leverages Paycycle to Cut Manual Spreadsheet Work, Delivering ROI in Less Than a Year
January 6, 2026

Payscale Customer Cheyenne Regional Medical Center Leverages Paycycle to Cut Manual Spreadsheet Work, Delivering ROI in Less Than a Year

Indeterminate GlobeNewswire
Built In Honors ReversingLabs in Its Esteemed 2026 Best Places To Work Awards
January 6, 2026

Built In Honors ReversingLabs in Its Esteemed 2026 Best Places To Work Awards

Indeterminate GlobeNewswire
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
January 6, 2026

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Indeterminate GlobeNewswire
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer
January 6, 2026

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

Indeterminate GlobeNewswire
Cerence AI to Participate in 28th Annual Needham Growth Conference
January 6, 2026

Cerence AI to Participate in 28th Annual Needham Growth Conference

Indeterminate GlobeNewswire
Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Compass Therapeutics Provides Corporate Update
January 6, 2026

Compass Therapeutics Provides Corporate Update

Indeterminate GlobeNewswire
Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)
January 6, 2026

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

Indeterminate GlobeNewswire
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions